SCHEMBL30107976

SCHEMBL30107976

COc1ccc2c(c1)nnn2-c1cc(C2CC(F)(F)C2)nc(N)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 3/20 0.34
HTT P42858 2/20 0.34
ALDH1A1 P00352 2/20 0.34
POLB P06746 2/20 0.34
HRH4 Q9H3N8 2/20 0.34
SCN2A Q99250 1/20 0.34
PDE2A O00408 3/20 0.33
PDE10A Q9Y233 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
IDH1 O75874 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTR3A P46098 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30107968 0.88 IDH1 (0.35) HTTALDH1A1POLBPDE2APDE10A
SCHEMBL30107957 0.84 HRH4 (0.32) HRH4PDE10AKDM4E
SCHEMBL30108038 0.76 PIM1 (0.46) HTTALDH1A1POLBHRH4SCN2A
SCHEMBL30107951 0.72 PTGS1 (0.46) HTTALDH1A1POLBMEN1KMT2A
SCHEMBL30108003 0.71 MET (0.40) ROCK1HTTALDH1A1POLBHRH4
SCHEMBL30108039 0.68 ALDH1A1 (0.40) ROCK1HTTALDH1A1POLBPDE2A
SCHEMBL30107975 0.67 L3MBTL1 (0.40) HTTALDH1A1POLBPDE2APDE10A
SCHEMBL30108036 0.65 PIM1 (0.46) HTTALDH1A1POLBPDE2APDE10A
Hydrochloric Acid SCHEMBL29769980 0.65 FGFR1 (0.57) ALDH1A1SMN1; SMN2NPSR1LMNACYP3A4
Hydrochloric Acid SCHEMBL26907985 0.65 FGFR1 (0.57) ALDH1A1SMN1; SMN2NPSR1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed